SecBot SecBot
SC 13G/A ·Filed Nov 18, 2026

XBIT

XBiotech Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed3d 13h ago SEC0001171843-26-007567
Passive stake amendment
Actionable Insight • Neutral

Monitor whether Thorpe converts to a Schedule 13D (activist) filing, which would signal a shift from passive to active engagement. The insider buying activity ($855K in 30 days) preceding this filing may indicate insider confidence.

DirectionNeutral
Confidencemedium
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$1.68
T+0 close · Nov 18, 2026 · via day close
Latest settled
+2.98%
T+1 · $1.73
Vs SPY
+6.62%
α at T+1
Next horizon
T+5
in 5d
  1. T+0 · Nov 19 $1.68entry
  2. T+1 · 2d ago +2.98%α +6.62% · $1.73
  3. T+5 · in 5d Pending
  4. T+20 · in 26d Pending
  5. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

McKenzie W. Thorpe filed an amended Schedule 13G disclosing beneficial ownership of 2,572,735 shares (8.4%) of XBiotech Inc., including shares underlying immediately exercisable stock options and shares held by the McKenzie Foundation. The stake increased from a prior filing, but no prior percentage or share count is provided in the documents for comparison.

Key Financial Metrics

Stake
8.4%
Investor
MCKENZIE W THORPE

Key Facts

  • McKenzie W. Thorpe reported beneficial ownership of 2,572,735 shares (8.4%) as of November 17, 2026.
  • Includes 2,505,987 shares directly held and 66,748 shares held by the McKenzie Foundation.
  • Percentage calculated on 30,487,731 shares outstanding plus 237,500 shares issuable upon exercise of stock options by the Reporting Person.
  • Filing is an amendment to Schedule 13G, indicating passive investor status.

Financial Impact

8.4% beneficial ownership stake in a $56M market cap company; no transaction value stated.

ownership percentage

Risk Factors

  • No prior filing data provided to assess the direction or magnitude of the stake change.
  • Passive 13G status could change to activist 13D if the investor engages in control-seeking activities.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001171843-26-007567
Document: 0001171843-26-007567-index.html0001171843-26-007567
Document: 0001171843-26-007567.txt0001171843-26-007567

Track record

5 reports on XBIT

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 18, 20263d ago SC 13G/A Neutral 3/10 Viewing Entry $1.68 Now $1.73 +2.98% settles Dec 18
  2. Oct 28, 202624d ago 3 Neutral 2/10 Entry $1.99 Now $1.73 −13.07% settles Nov 25
  3. Oct 26, 202626d ago 8-K Neutral 3/10 Entry $1.85 Now $1.73 −6.49% settles Nov 23
  4. Oct 2, 20267w ago DEF 14A Bearish 5/10 Entry $2.19 to $1.88 Now $1.73 +21.00% ▲ +14.16% +12.35% vs SPY
  5. Apr 29, 202629w ago 10-K/A Neutral 2/10 Entry $2.52 to $2.44 Now $1.73 −31.35% ▼ −3.17% −8.63% vs SPY
Showing 5 of 5

US Market Status

Market Closed · Opens Mon (26h 12m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 18, 2026